Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study

Arch Dermatol Res. 1993;285(4):221-6. doi: 10.1007/BF00372013.

Abstract

In a bilaterally paired double-blind comparison study, a cream containing 0.1% 13-cis-retinoic acid (13-cis-RA) and cream base only were applied over 4 weeks in seven patients with non-erythrodermic lamellar ichthyosis (NELI), two patients with Darier's disease and one patient with autosomal dominant ichthyosis vulgaris (ADIV). In two patients with NELI and two patients with Darier's disease a half-side effect was observed in favour of the side treated with 13-cis-RA. In three patients an induction of cytokeratin-4, and in one of these patients expression of cytokeratin-13, were observed after therapy. Topical 13-cis-RA appears to be a promising approach in the treatment of disorders of keratinization. The selective modulation of the cytokeratin pattern may provide an immunohistochemical tool to investigate the mode of action of retinoids.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Antibodies, Monoclonal
  • Darier Disease / drug therapy*
  • Double-Blind Method
  • Female
  • Humans
  • Ichthyosis, Lamellar / drug therapy*
  • Immunoenzyme Techniques
  • Isotretinoin / administration & dosage*
  • Keratins / analysis
  • Male

Substances

  • Antibodies, Monoclonal
  • Keratins
  • Isotretinoin